Despite this activation, sequencing of exons 19-21 of EGFR in the 2 human adenocarcinomas of the middle ear did not reveal activating or resistance mutations (data not shown), suggesting other mechanism for EGFR activation. This evidence concerns the gene EGFR and adenocarcinoma.